Advertisement

Topics

Companies Related to "A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study" [Most Relevant Company Matches] RSS

00:01 EST 23rd February 2019 | BioPortfolio

Here are the most relevant search results for "A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study" found in our extensive corporate database of over 50,000 company records.

Showing "Comparison Methotrexate Alone Combined Infliximab Pulse Methylprednisolone Early" Companies 1–25 of 1,300+

Relevant

PulseOximetersDIRECT.com

PulseOximetersDIRECT.com(TM) is the trusted leader in providing the highest quality, lowest-cost, FDA approved pulse oximeters in the industry. PulseOximetersDIRECT.com(TM) specializes in Finger Pulse Oximeters, Hand Held Pulse Oximeters, Pediatric Pulse Oximeters, and Sleep Apnea Oximeters.


Carclo plc

The company remains committed to the highest standards of corporate governance and manages its affairs in accordance with the 2003 FRC Combined Code on Corporate Governance (“the Combined Code”) published in July 2003. The company has complied throughout the year with the provisions set out in the Combined Code except where noted on page 26. This statement, together with the directors’ remun...

Pulse Systems, Inc.

Pulse develops, markets, and supports products and services that integrate workflow automation into the healthcare management process; simplifying workflow and improving quality of care and profitability. Pulse is a premier provider of Electronic Health Records (EHR), Practice Management, ePrescribing and Revenue Cycle Management (...


New England Compounding Center

“New England Compounding Center (NECC) is working closely with the Massachusetts Board of Pharmacy, the Centers for Disease Control and the U.S. Food and Drug Administration on their investigation into the cause of infection in patients who received injections of methylprednisolone acetate. As part of this process, NECC has initiated a series of recalls ...

Pulse Electronics

Pulse Electronics is the electronic components partner that helps customers build the next great product by providing the needed technical solutions. Pulse Electronics has a long operating history of innovation in magnetics, antennas, and connectors, and can ramp quickly into high-quality, high-volume production.

Pulse Biosciences, Inc.

Pulse Biosciences is a medical technology company developing a therapeutic tissue treatment platform based on Nano-Pulse Stimulation, a proprietary cell signaling technology. Published pre-clinical studies have shown that a single, brief exposure of Nano-Pulse Stimulation to target tissue stimulates a cascade of events within cells and in the surrounding m...

Combined Insurance

Combined Insurance is a leading provider of individual supplemental accident, disability, health and life insurance products and part of the ACE Group of Companies. With a field sales force and corporate staff in excess of 5,000 people worldwide, Combined Insurance meets the growing coverage needs of policyholders around the globe. For more information, ca...

Cyto Pulse Sciences, Inc.

Cyto Pulse Sciences, Inc. is a biomedical device and treatment development company creating innovative technology to produce and deliver new therapeutics for cancer (immunotherapy), infectious diseases (prophylaxis therapy), and genetic defects (gene therapy). Cyto Pulse technology is used in a wide range of fields including monoclonal antibody discovery, ...

Virgin Pulse

Virgin Pulse, part of Sir Richard Branson’s famed Virgin Group, helps employers create a workforce with the energy, focus, and drive necessary to fully engage at work and in life. With its award-winning, online platform, the company fosters healthy daily habits and sustainable behavior change that help employees thrive at work and across all aspects o...

Pulse Health

Pulse Health was established in 2006 to deliver breakthrough breath technologies that can better identify health risks through the superior measurement of key biomarkers. Pulse Health has a science advisory board of nine physicians and scientists from around the world, representing the leaders in exhaled breath diagnostics, pulmonary disease, immunology, n...

Pulse Metric, Inc

Physicist Shiu-Shin Chio, Ph.D., founded Pulse Metric in 1990 and serves as Chairman of the Board. His founding vision continues to guide the company today: To apply principles of biophysics and computer technologies to the development of advanced non-invasive tools that will help clinicians better detect and treat hypertension, heart failure and associated cardiovascular disease.Pulse Metric, Inc...

Pulse Veterinary Technologies, LLC

Pulse Veterinary Technologies, LLC, located in Alpharetta, Ga., is a privately held company which develops and markets innovative, less-invasive therapies for the veterinary market. The company’s principal technology is the VersaTron® family of products for the management of a variety of musculoskeletal disorders causing chronic pain and lameness. ...

Cardiac Regeneration Technologies

CRT is a privately held medical device company based out of Woodstock, Georgia. CRT focuses its efforts on the use of pressure pulse technology and therapy on cardiovascular conditions. CRT designed and developed its patent pending CardioGold pressure pulse device and underlying patented direct epicardial therapy over a four year period commencing in 200...

Cyto Pulse Sciences, Inc

Cyto Pulse was founded in December 1995 and is incorporated as a regular corporation in Maryland. The company is composed of a multidisciplinary staff of engineers and scientists. Cyto Pulse develops electric field based devices for use in vaccine delivery, vaccine production, personal vaccine production, gene therapy, and hybridoma production. In recent years, there have been great advances in im...

Cyto Pulse Sciences Incorporated

Cyto Pulse and its collaborators are finding solutions to human diseases that have never been treated successfully before. Core electric field waveform technology enables researchers to make advances in cell fusion and gene delivery for treating and preventing incurable disorders such as cancer and genetic deficiencies. Safe, efficient and repeatable, this technology is covered by a number of meth...

Masimo Corporation

Founded in 1989, Masimo Corporation, the innovator of motion and low perfusion tolerant pulse oximetry, is a privately held medical technology company that develops, licenses and markets advanced medical signal processing technologies and products for the noninvasive monitoring of patient vital signs.Masimo Signal Extraction Technology pulse oximetry, Masimo SET®, represents a fundamental departu...

Sunshine Heart, Inc.

Sunshine Heart (ASX:SHC) is a global medical device company committed to novel cardiac and coronary therapy. The company is currently developing the C-Pulse® Heart Assist System, an implantable, non-blood contacting, heart assist therapy for the treatment of moderate to severe heart failure which can be implanted using a minimally invasive procedure. C-...

Masimo

Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care--helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and o...

Abreos Biosciences

Abreos Biosciences is focused on ligand binding assays for biologic and biosimilar drug development, activity validation, authentication, and precision dosing, as well as massively multiplexed biomarker assays. Abreos has already developed reagents for the detection of several drugs currently available on the market such as rituximab, obinutuzumab, trastuz...

The Virgin Pulse Institute

Tosk Inc.

Tosk was founded in 1998 to discover new drugs for genetic diseases and cancer. The original technology, in part licensed from Stanford University,StealthGene and Targeted Gene Delivery technologies. In the process, Tosk discovered and perfected the Optimizing Marketed Drugs side-effect-reducing drugs.Tosk's current drug discovery and development efforts focus on applying the OMD approach to disco...

CoreLab Partners, Inc

CoreLab Partners, with offices in North America, Europe and Asia, provides comprehensive medical image assessment and cardiac safety services to the pharmaceutical, biotechnology and medical device industries. An efficient operational process facilitates successful new drug development programs by employing an experienced clinical operations team combined ...

Pulse Metric

Physicist Shiu-Shin Chio, Ph.D., founded Pulse Metric in 1990 and serves as chief executive officer. His founding vision continues to guide the company today: To apply principles of biophysics and computer technologies to the development of advanced non-invasive tools that will help clinicians better detect and treat hypertension, heart failure and associated cardiovascular disease.The company's D...

Nippon Pulse

Since its founding in 1952, Nippon Pulse Motor Co., Ltd., as a total system maker of a variety of motors, drivers, controllers, actuators and mechatronic systems (which have high control properties), has supplied high-quality products to a wide range of industries.NPM's flexible business activities are spread over a broad range of areas, including motion control systems, and exhibit high productiv...

Probably Relevant

Battelle Ventures

Battelle Ventures, L.P., and its affiliate fund, Innovation Valley Partners (IVP), have a combined $255 million under management for creating and accelerating the development of early-stage technology companies with breakthrough solutions to key marketplace problems. The funds have enjoyed close relationships with the technology transfer offices of the Nat...


More From BioPortfolio on "A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks